 ImmuCell Corporation Nasdaq: ICCC ImmuCell or the Company, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, will report unaudited financial results for the year ended December 31, 2019 after the market closes on Tuesday, February 18, 2020. The Company has scheduled a conference call on Wednesday, February 19, 2020 at 9:00 AM ET to review the 2019 results. Investors are encouraged to review the Companys updated Corporate Presentation slide deck that provides an overview of the Companys business and is available under the Investors tab of the Companys website at or by request to the Company. 